In a study cohort that included a total of 2,674,051 screening mammograms, these factors were found to result in the highest recall rates. 

While FIF is an extremely rare condition—occurring in about one in 500,000 births—it is even more rare in triplet pregnancies.

Connie Lehman, MD, PhD, chief of breast imaging, co-director of the Avon Comprehensive Breast Evaluation Center at the Massachusetts General Hospital, discusses the challenges of the COVID-19 pandemic on breast screenings, increased cancer rates and issues with the vaccines causing false positives on mammograms.

Almost half of U.S. women covered by or eligible for Medicare have not been screened for breast cancer for at least three years, according to a study just out from the Radiology Business Management Association.

Connie Lehman, MD, PhD, chief of breast imaging, co-director of the Avon Comprehensive Breast Evaluation Center at the Massachusetts General Hospital, explains why she thinks contrast-enhanced mammography will likely become the go-to supplemental imaging modality for women with dense breasts.

The oft-belittled dried fruit may punch above its weight when helping postmenopausal women beat back inflammation, according to two new Penn State studies.
 

Might mammography enhanced by contrast media prove a surer, faster way than other modalities—including digital breast tomosynthesis—to get to a definitive diagnosis for women with dense breast tissue? The American College of Radiology wants to know.

Radiomics methodologies could change how care plans are managed for patients with breast cancer by identifying those most likely to benefit from specific treatments.